STAT3 and gastric cancer: This study found that SLCO4A1-AS1 has a cancer-promoting effect in gastric cancer cells, which may regulate the biological characteristics of gastric cancer cells by targeting STAT3 with miR-149-5p, suggesting that SLCO4A1-AS1 may be used for the treatment of gastric cancer.